Beam Therapeutics (BEAM)
(Delayed Data from NSDQ)
$26.81 USD
+2.29 (9.34%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $26.85 +0.04 (0.15%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-1.13 | 1.29% |
Earnings Summary
For their last quarter, Beam Therapeutics (BEAM) reported earnings of -$1.11 per share, beating the Zacks Consensus Estimate of $-1.13 per share. This reflects a positive earnings surprise of 1.77%. Look out for BEAM's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$1.13 per share, reflecting a year-over-year increase of 7.38%.
Earnings History
Price & Consensus
Zacks News for BEAM
Beam Therapeutics (BEAM) Q2 Earnings Beat, Revenues Miss
BEAM: What are Zacks experts saying now?
Zacks Private Portfolio Services